Gradewell Pharmaceutical Private Limited
About Gradewell Pharmaceutical Private Limited
Data last updated:
Gradewell Pharmaceutical Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33300MH2018PTC307919. Its GSTIN is 27AAHCG2721N1ZE (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Chandra Kumar Shukla and Poonam Shukla Chandra Kumar.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No.09 Sr No. 38 Sanjari Apartment Hi Tenson Road Pragati Nagar Nallasopara, Thane, Maharashtra, India – 401209.
As per the financials filed for FY 2025, the company reported a revenue of ₹23.7 Lakh, a decline of 3% compared to the previous year. For the same year it recorded a net loss of ₹85,504 (net margin -3.6%) and EBITDA of -₹73,893 (EBITDA margin -3.1%). Revenue has grown at a compounded annual rate (CAGR) of 114% over three years and 14% over five years.
Company details
Contact details
Gradewell Pharmaceutical Private Limited's registered office is in Thane, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressShop No.09 Sr No. 38 Sanjari Apartment Hi Tenson Road Pragati Nagar Nallasopara, Thane, Maharashtra, India – 401209
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Gradewell Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Gradewell Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Gradewell Pharmaceutical Private Limited, buy the company report.
Financials of Gradewell Pharmaceutical Private Limited
FY 2025 filings availableGradewell Pharmaceutical Private Limited reported revenue of ₹23.7 Lakh (down 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 3% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 14%. EBITDA rose 65% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹73,893 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹85,504 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -3.1% | ||||
| Net Profit Margin | -3.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Gradewell Pharmaceutical Private Limited, buy the company report.
Board of directors of Gradewell Pharmaceutical Private Limited
Gradewell Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandra Kumar Shukla | Director | 12 Apr 2018 | 8 Years 6 Months | Current |
| Poonam Shukla Chandra Kumar | Director | 12 Apr 2018 | 8 Years 6 Months | Current |
Peer comparison
Gradewell Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Drixty Chemconcerns (OPC) Private Limited | ₹23.83 Lakh (FY 2021) | Vadodara, Gujarat, India | ||||
| NSN United Private Limited | ₹23.78 Lakh (FY 2023) | 1005.0% | Madhubani, Bihar, India | |||
| DLR Pharmatech Private Limited | ₹23.78 Lakh (FY 2022) | Hyderabad, Telangana, India | ||||
| Calsmelt Metaliks Private Limited | ₹23.76 Lakh (FY 2025) | -91.0% | Kolkata, West Bengal, India | |||
| Avudai Innovatives Private Limited | ₹23.72 Lakh (FY 2018) | -76.0% | Tiruvallur, Tamil Nadu, India | |||
| Gradewell Pharmaceutical Private Limitedthis company | ₹23.7 Lakh (FY 2025) | -₹85,504 | -3.6% | -3.0% | Thane, Maharashtra, India | |
| Phlox Laboratories Private Limited | ₹23.68 Lakh (FY 2024) | -18.0% | Lucknow, Uttar Pradesh, India | |||
| SNH Pharma Private Limited | ₹23.62 Lakh (FY 2024) | 139.0% | Vadodara, Gujarat, India | |||
| Pinkpepper Concepts Private Limited | ₹23.59 Lakh (FY 2024) | 273.0% | New Delhi, Delhi, India | |||
| Aditya Bioinnovation Private Limited | ₹23.58 Lakh (FY 2025) | -46.0% | Nagpur, Maharashtra, India | |||
| Kayakarpa Organic Farm Private Limited | ₹23.5 Lakh (FY 2024) | 2162.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Gradewell Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Gradewell Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Gradewell Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Gradewell Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCG2721N1ZE | Maharashtra | Active | 28 Aug 2018 |
To see the full GST registrations and return filing status of Gradewell Pharmaceutical Private Limited, buy the company report.
Recent activity
Gradewell Pharmaceutical Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Chandra Kumar Shukla was appointed as Director on 12 Apr 2018.
Frequently asked questions
Gradewell Pharmaceutical is an active private limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 April 2018 (8+ years old) and is registered under CIN U33300MH2018PTC307919.
Gradewell Pharmaceutical has 2 current directors:
- Chandra Kumar Shukla - Director
- Poonam Shukla Chandra Kumar - Director
The latest financial statements of Gradewell Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Gradewell Pharmaceutical is 27AAHCG2721N1ZE, registered in Maharashtra.
The CIN (Corporate Identification Number) of Gradewell Pharmaceutical is U33300MH2018PTC307919. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gradewell Pharmaceutical was incorporated on 12 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Gradewell Pharmaceutical by revenue are Drixty Chemconcerns (OPC) Private Limited, NSN United Private Limited, DLR Pharmatech Private Limited, Calsmelt Metaliks Private Limited, Avudai Innovatives Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Chandra Kumar Shukla was appointed as Director on 12 Apr 2018. Poonam Shukla Chandra Kumar was appointed as Director on 12 Apr 2018.
The registered office of Gradewell Pharmaceutical is at Shop No.09 Sr No. 38 Sanjari Apartment Hi Tenson Road Pragati Nagar Nallasopara, Thane, Maharashtra, India – 401209.
Gradewell Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Gradewell Pharmaceutical can be reached at its registered office: Shop No.09 Sr No. 38 Sanjari Apartment Hi Tenson Road Pragati Nagar Nallasopara, Thane, Maharashtra, India – 401209.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
